Highlights Lupin Limited NSE India S.E.

Equities

LUPIN

INE326A01037

Delayed NSE India S.E. Other stock markets 02:24:52 2024-07-18 am EDT			5-day change	1st Jan Change
1,829 ^INR	-0.89%		+0.61%	+38.21%

Jul. 16	Lupin Sells US Commercial Women's Health Specialty Business to Evofem Biosciences	MT
Jul. 15	Lupin Gets Establishment Inspection Report from US FDA After Dabhasa Unit, Inspection	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lupin Sells US Commercial Women's Health Specialty Business to Evofem Biosciences	Jul. 16	MT
Lupin Gets Establishment Inspection Report from US FDA After Dabhasa Unit, Inspection	Jul. 15	MT
Evofem Bio.sciences, Inc. acquired Womens Health Specialty Business of Lupin Limited for $84 million.	Jul. 14	CI
INDIA STOCKS-IT leads Indian shares to record highs	Jul. 04	RE
India plans incentives for diabetes, obesity drug makers in 2026, government official says	Jun. 28	RE
Indian Equities Fall on Friday, Dragged Mainly by Banking Stocks	Jun. 28	MT
Lupin Loses Appeal Against EU Anti-Trust Fine	Jun. 28	MT
Lupin Gets Zero Observations from US FDA After Nagpur, India Unit Inspection	Jun. 14	MT
Lupin Arm Acquires Two Brands from Sanofi in Europe and Canada	Jun. 05	MT
India's pharma export sales to grow faster this year, trade body says	May. 30	RE
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research	May. 27	RE
Lupin Gets Six Observations from US FDA After Somerset Unit Inspection	May. 20	MT
Lupin's Consolidated Profit Climbs in Fiscal Q4; Shares Dip 4%	May. 07	MT
Indian drugmaker Lupin misses quarterly profit estimates as costs rise	May. 06	RE
Lupin Limited Recommends Dividend for the Year Ended March 31, 2024	May. 06	CI
Lupin Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 06	CI
Lupin Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 06	CI
Lupin Limited Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP	May. 06	CI
Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility	Apr. 23	MT
INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains	Apr. 22	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Lupin Limited NSE India S.E.

Equities

LUPIN

INE326A01037

Highlights

Filters